ArticleNaunyn-Schmiedeberg's archives of pharmacology2013

Olmesartan decreases IL-1β and TNF-α levels; downregulates MMP-2, MMP-9, COX-2, and RANKL; and upregulates OPG in experimental periodontitis.

Aurigena Antunes Araújo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.